FDA approves Roche’s Tecentriq plus Cotellic and Zelboraf for people with advanced melanoma Read more
Pfizer and BioNTech to Supply Japan with 120 Million Doses of their BNT162 mRNA-based Vaccine Candidate Read more
Sanofi and GSK in advanced discussions with European Union to supply up to 300 million doses of COVID-19 vaccine Read more
FDA approves Roche’s Tecentriq plus Cotellic and Zelboraf for people with advanced melanoma Read more
SAB Biotherapeutics Announces First Participant Dosed in Phase 1 Clinical Trial of SAB-176 for Seasonal Influenza Read more
Takeda Announces FDA Breakthrough Therapy Designation Granted for Pevonedistat for the Treatment of Patients with HR-MDS Read more
Sangamo Announces Global Collaboration With Novartis to Develop Genomic Medicines for Autism and Other Neurodevelopmental Disorders Read more
Sanofi and GSK agree with the UK government to supply up to 60 million doses of COVID-19 vaccine Read more
Single Dose of Johnson & Johnson COVID-19 Vaccine Candidate Demonstrates Robust Protection in Pre-clinical Studies Read more